Signed · Germany · Pharma and biotech
Telix agrees to acquire ITM.
Telix Pharmaceuticals, based in Melbourne, Australia, signed a share purchase agreement on 21 September 2026 to acquire all shares of ITM Isotope Technologies Munich SE, a radiopharmaceutical company headquartered in Munich, Germany. Part of the price is paid in new Telix shares, and ITM shareholders would hold about 23.7 percent of Telix on completion. It was signed on 21 September 2026. It had not completed by 28 October 2026.
Signing 21 September 2026
- Buyer
- Telix Pharmaceuticals Limited ·Melbourne, Australia
- Target
- ITM Isotope Technologies Munich SE ·Munich, Germany
- Type
- Acquisition
- Announced
- 21 September 2026
- Signed
- 21 September 2026
- Value
- USD 1.65 billion plus up to USD 700 million contingent
- People
- Not stated in the release
- Last checked
- 28 October 2026
The people side in Germany
- Above 100 employees, the economic committee is told of the change of control, the buyer and its intentions. Works Constitution Act (BetrVG), section 106
- In an asset or business transfer, staff move to the buyer on existing terms and dismissal for the transfer is invalid. Each may object within one month of being informed. Civil Code (BGB), section 613a
- Where combined worldwide turnover exceeds EUR 500 million and one party has over EUR 50 million and another over EUR 17.5 million in Germany, the deal may not complete before Bundeskartellamt clearance. Act against Restraints of Competition (GWB), sections 35, 39 and 41
- Non-EU buyers reaching 25% of a German company's votes can be screened; in 27 listed sensitive activities, 10% or 20% is notified and the deal waits for clearance. Foreign Trade and Payments Ordinance (AWV), sections 55, 55a and 56, with Foreign Trade and Payments Act (AWG), section 15
- An employer with staff in German social insurance obtains a company number (Betriebsnummer) for each establishment; an employer without a seat in Germany also appoints a representative based there. Social Code Book IV (SGB IV), sections 18i and 28f(1b)
- Where the deal needs EU merger clearance, the buyer may not implement it before clearance. EU Merger Regulation (Council Regulation (EC) No 139/2004), article 7
Octagon runs payroll in Germany for international buyers, with or without a local entity of their own.
Related deals
- 3 Nov
HRV Global Life Sciences Private Limited (through New Horizon Pharma B.V.)to
Phatebo GmbHdeal page: HRV Pharma agrees to acquire PhateboSigned
not statedSigningDay 100 - 17 Nov
Dacke Industri ABto
ASO Safety Solutions GmbHdeal page: Dacke Industri takes a majority stake in ASO Safety SolutionsCompleted
about 150SigningDay 100 - 13 Nov
Fusion CX Limitedto
impacxdeal page: Fusion CX agrees to acquire impacxSigned
around 250SigningDay 100 - 11 Nov
H.I.G. Capital, L.L.C.to
go asiadeal page: H.I.G. Capital agrees to acquire a majority stake in go asiaSigned
more than 1,600SigningDay 100